Articles dans des revues avec comité de lecture (396)
  1. 349. Atalay, G., Cardoso, F., Awada, A., & Piccart-Gebhart, M. (2003). Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer. Annals of oncology, 14(9), 1346-1363. doi:10.1093/annonc/mdg365
  2. 350. Awada, A., Thödtmann, R., Piccart-Gebhart, M., Wanders, J., Schrijvers, A. H. G. J., Von Broen, I.-M., Hanauske, A.-R., & EORTC-ECSG phase I study, (2003). An EORTC-ECSG phase I study of LU 79553 administered every 21 or 42 days in patients with solid tumours. European journal of cancer, 39(6), 742-747.
  3. 351. Pivot, X., Awada, A., Gedouin, D., Kerger, J., Rolland, F., Cupissol, D., Caponigro, F., Comella, G., Lopez-Pousa, J. J., Guardiola, E., Giroux, B., Gérard, B., & Schneider, M. (2003). Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancer. Annals of oncology, 14(3), 373-377.
  4. 352. Vereecken, P., Mathieu, A., Laporte, M., Petein, M., Velu, T., Awada, A., & Heenen, M. (2003). Management of cutaneous locoregional recurrences of melanoma: a new therapeutic perspective with imiquimod. Dermatology, 206(3), 279-280. doi:10.1159/000068901
  5. 353. Piccart-Gebhart, M., Floquet, A., Scarfone, G., Willemse, P. H. B., Emerich, J., Vergote, I., Giurgea, L., Coens, C., Awada, A., & Vermorken, J. B. (2003). Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy. International journal of gynecological cancer, 13 Suppl 2, 196-203.
  6. 354. Awada, A. (2003). Relapsing ovarian cancer: selection of the therapeutic agent. UpToDate in Oncology, 2.
  7. 355. Awada, A., Giacchetti, S., Gérard, B., Eftekhary, P., Lucas, C., de Valeriola, D., Poullain, M. G., Soudon, J., Dosquet, C., Brillanceau, M.-H., Giroux, B., Marty, M., Bleiberg, H., Calvo, F., & Piccart-Gebhart, M. (2002). Clinical phase I and pharmacokinetic study of S 16020, a new olivacine derivative: report on three infusion schedules. Annals of oncology, 13(12), 1925-1934. doi:10.1093/annonc/mdf321
  8. 356. Awada, A., Eskens, F. A., Piccart-Gebhart, M., Cutler, D. L., van der Gaast, A., Bleiberg, H., Wanders, J., Faber, M., Statkevich, P., Fumoleau, P., & Verweij, J. (2002). Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours. European journal of cancer, 38(17), 2272-2278. doi:10.1016/S0959-8049(02)00379-9
  9. 357. Awada, A., Biganzoli, L., Cufer, T., Beex, L., Lohrisch, C., Batter, V., Hamilton, A., Nooij, M., & Piccart-Gebhart, M. (2002). An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes. European journal of cancer, 38(6), 773-778.
  10. 358. Awada, A. (2002). New cytotoxic agents and molecular-targeted therapies in the treatment of metastatic breast cancer. Forum (Genoa, Italy), 12(1), 4-15.
  11. 359. Freyer, G., Hennebert, P., Awada, A., Gil, T., Kerger, J., Selleslags, J., Brassinne, C., Piccart-Gebhart, M., & de Valeriola, D. (2002). Influence of Amifostine on the toxicity and pharmacokinetics of docetaxel in metastatic breast cancer patients: a pilot study. Clinical cancer research, 8(1), 95-102.
  12. 360. Hamilton, A., Biganzoli, L., Coleman, R., Mauriac, L., Hennebert, P., Awada, A., Nooij, M., Beex, L., Piccart-Gebhart, M., Van Hoorebeeck, I., Bruning, P., & de Valeriola, D. (2002). EORTC 10968: A phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx®, Doxil®) at a 6-week interval in patients with metastatic breast cancer. Annals of oncology, 13(6), 910-918. doi:10.1093/annonc/mdf157
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 39 Suivant >>